The Toxin Probes and Assays Core will provide analytical support to each of the four projects. Support will be in the form of (1) toxin standards, (2) anti-toxin antibodies and synaptosomes as reagents for specific binding assays, (3) toxin derivatives that may encompass metabolites, conjugates, and photolysis products, (4) Fourier transform infrared and nuclear magnetic and proton and carbon) resonance spectrometry of standards and synthetic metabolites or proto-products, and (5) high performance liquid chromatographic analysis. For Research Project 1, the core anticipates support items (1), photolytic (3), and (5) to be the most important. For Research Project 2, support items (1), (2), (3) and (5) will be essential. For Research Project (3) toxin derivatives that may encompass metabolites, conjugates, and photolysis products, (4) Fourier transform infrared and nuclear magnetic (proton and carbon) resonance spectrometry of standards and synthetic metabolites or proto- products, and (5) high performance liquid chromatographic analysis. For Research Project 1, the core anticipates support items (1), photolytic (3), and (5) to be the most important. For Research Project 2, support items (1), (2) , (3) and (5) will be essential. For Research Project 2, 3, support items (1) and (2) will provide the most benefit. For Research Project 4, support items (1) and (2) will be the most important. The core will also provide antibodies and reagent toxins to Facilities Core 2, the Immunocytochemistry Core, so that immunoperoxidase assays an be carried out relative to phagocytic accumulation and biomarker assay development. This relative to phagocytic accumulation and biomarker assay development. This latter effort will require synthesis of antibody- HRP conjugates and measurement of specific enzymatic activity per binding unit. To carry out this Program efficiently, Dr. Baden will oversee the core s functions, determine the level of effort to be expended on each project, identify the standards assays, and derivatives that will be of most use, and work with the 2 research associates to provide the materials and assay logistics and a timely manner. The two research associates will receive samples, isolate quantitatively and identify the components, develop synthetic methods to produce sufficient quantities for controlled experiments, and provide advice to individual projects pertaining to amounts of material to collect, methods of preservation, and methods of transport.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Program Projects (P01)
Project #
5P01ES010594-02
Application #
6485255
Study Section
Special Emphasis Panel (ZES1)
Project Start
2001-07-01
Project End
2002-06-30
Budget Start
Budget End
Support Year
2
Fiscal Year
2001
Total Cost
$179,092
Indirect Cost
Name
University of North Carolina Wilmington
Department
Type
DUNS #
040036584
City
Wilmington
State
NC
Country
United States
Zip Code
28403
McCall, Jennifer R; Goodman, Allan J; Jacocks, Henry M et al. (2014) Development of a fluorescence assay for the characterization of brevenal binding to rat brain synaptosomes. J Nat Prod 77:2014-20
McCall, Jennifer R; Jacocks, Henry M; Niven, Susan C et al. (2014) Development and utilization of a fluorescence-based receptor-binding assay for the site 5 voltage-sensitive sodium channel ligands brevetoxin and ciguatoxin. J AOAC Int 97:307-15
Goodman, Allan; McCall, Jennifer R; Jacocks, Henry M et al. (2014) Structure activity relationship of brevenal hydrazide derivatives. Mar Drugs 12:1839-58
Gold, Elena P; Jacocks, Henry M; Bourdelais, Andrea J et al. (2013) Brevenal, a brevetoxin antagonist from Karenia brevis, binds to a previously unreported site on mammalian sodium channels. Harmful Algae 26:12-19
McCall, Jennifer R; Jacocks, Henry M; Baden, Daniel G et al. (2012) Development of a competitive fluorescence-based synaptosome binding assay for brevetoxins. Harmful Algae 19:85-91
Zhou, Yue; Sun, Jaijie; Cheng, Yung-Sung (2011) Comparison of deposition in the USP and physical mouth-throat models with solid and liquid particles. J Aerosol Med Pulm Drug Deliv 24:277-84
Bean, Judy A; Fleming, Lora E; Kirkpatrick, Barbara et al. (2011) Florida Red Tide Toxins (Brevetoxins) and Longitudinal Respiratory Effects in Asthmatics. Harmful Algae 10:744-748
Benson, Janet M; Wolf, Molly L; Kajon, Adriana et al. (2011) Brevetoxin inhalation alters the pulmonary response to influenza A in the male F344 rat. J Toxicol Environ Health A 74:313-24
Murrell, Rachel N; Gibson, James E (2011) Brevetoxin 2 alters expression of apoptotic, DNA damage, and cytokine genes in Jurkat cells. Hum Exp Toxicol 30:182-91
Fleming, Lora E; Kirkpatrick, Barbara; Backer, Lorraine C et al. (2011) Review of Florida Red Tide and Human Health Effects. Harmful Algae 10:224-233

Showing the most recent 10 out of 85 publications